U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
165601165601BHS4 - Bone/Muscle Changes Following Hip Fracture in Older White WomenCompletedNo Results AvailableHip FractureBehavioral: Exercise Plus Programhttps://ClinicalTrials.gov/show/NCT00390741
165602165602Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial)CompletedNo Results AvailableDiabetes Mellitus, Type 1Drug: Insulin Glarginehttps://ClinicalTrials.gov/show/NCT00390728
165603165603Treatment of Acute Myeloblastic Leukemia in Younger PatientsCompletedNo Results AvailableAcute Myeloblastic LeukemiaDrug: chemotherapyhttps://ClinicalTrials.gov/show/NCT00390715
165604165604Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil SystemSuspendedNo Results AvailableHeart Septal Defects, VentricularDevice: transcatheter implantation of a VSD occluder (Nitinol coil)https://ClinicalTrials.gov/show/NCT00390702
165605165605A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS.CompletedHas ResultsIdiopathic Restless Legs SyndromeDrug: Pramipexole 0.125 mg tablet|Drug: Pramipexole 0.5 mg tablethttps://ClinicalTrials.gov/show/NCT00390689
165606165606A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or CapecitabineCompletedNo Results AvailableNeoplasmsDrug: ADH -1 and carboplatin|Drug: ADH -1 and docetaxel|Drug: ADH -1 and capecitabinehttps://ClinicalTrials.gov/show/NCT00390676
165607165607A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in ChildrenRecruitingNo Results AvailableEpistaxisProcedure: Nasal Cauteryhttps://ClinicalTrials.gov/show/NCT00390663
165608165608A North-American Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety DisorderCompletedNo Results AvailableAnxietyDrug: Saredutanthttps://ClinicalTrials.gov/show/NCT00390650
165609165609Diet, Obesity and Genes (DiOGenes)Active, not recruitingNo Results AvailableObesity|Metabolic Syndrome|Type 2 Diabetes|Cardiovascular DiseaseBehavioral: High or low Glycemic Index and high or low Protein Diethttps://ClinicalTrials.gov/show/NCT00390637
165610165610Prevention Of Nephrotoxicity Following Bone Marrow Transplantation Using Urodilatin and MannitolCompletedNo Results AvailableRenal Dysfunction|Acute Renal Failure|MortalityDrug: URODILATIN (ULARITIDE, ATRIAL NATRIURETIC PEPTIDE)|Drug: MANNITOLhttps://ClinicalTrials.gov/show/NCT00390624
165611165611Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian CancerCompletedHas ResultsOvarian CancerDrug: Sorafenib|Drug: Paclitaxel|Drug: Carboplatinhttps://ClinicalTrials.gov/show/NCT00390611
165612165612PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to ColonoscopyCompletedNo Results AvailableColonoscopyDrug: PEG (solution given 4 L)|Drug: senna glycoside 36 mg and PEG (solution given 2 L)https://ClinicalTrials.gov/show/NCT00390598
165613165613Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST)CompletedNo Results AvailableRenal Insufficiency, Chronic|Angioplasty, Transluminal, Percutaneous Coronary|Coronary ArteriosclerosisDrug: Iodixanol 320|Drug: Iomeprol 350https://ClinicalTrials.gov/show/NCT00390585
165614165614Sleep Specialty Consultation: Improving Management of Sleep DisordersCompletedHas ResultsSleep DisordersBehavioral: Sleep Specialty Consultationhttps://ClinicalTrials.gov/show/NCT00390572
165615165615Examining the Effect of the Nicotine Patch in Male and Female Smokers - 3CompletedHas ResultsDrug Addiction|Smoking CessationDrug: nicotine transdermal system|Drug: Nicotine transdermal system|Other: Nicotine containing cigarette|Other: Placebo cigarettehttps://ClinicalTrials.gov/show/NCT00390559
165616165616Multicenter Study of Antiarrhythmic Medications for Treatment of Infants With Supraventricular TachycardiaCompletedHas ResultsSupraventricular TachycardiaDrug: Digoxin|Drug: Propranololhttps://ClinicalTrials.gov/show/NCT00390546
165617165617An Eight-week Study to Evaluate the Efficacy and Safety of 2 Doses of Saredutant in Patients With Generalized Anxiety DisorderCompletedNo Results AvailableGeneralized AnxietyDrug: Saredutant|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00390533
165618165618Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: Vildagliptinhttps://ClinicalTrials.gov/show/NCT00390520
165619165619Modification of Posttetanic Count (PTC) for Monitoring Deep Neuromuscular Block IICompletedNo Results AvailableNeuromuscular BlockadeProcedure: Post-tetanic count frequencyhttps://ClinicalTrials.gov/show/NCT00390507
165620165620Questionnaire Study to Assess Quality of Life After Treatment of FibroidsActive, not recruitingNo Results AvailableLeiomyomaProcedure: Hysterectomy|Procedure: Myomectomy|Procedure: Uterine Fibroid Embolizationhttps://ClinicalTrials.gov/show/NCT00390494
165621165621Study of Carotid Occlusion and NeurocognitionCompletedNo Results AvailableCarotid Artery DiseasesProcedure: EC-IC Bypass in the COSS studyhttps://ClinicalTrials.gov/show/NCT00390481
165622165622Tandutinib in Treating Patients With Progressive Prostate Cancer and Bone MetastasesCompletedHas ResultsMetastatic Cancer|Pain|Prostate CancerDrug: Tandutinibhttps://ClinicalTrials.gov/show/NCT00390468
165623165623Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-PositiveActive, not recruitingHas ResultsEstrogen Receptor Positive|HER2 Positive Breast Carcinoma|HER2/Neu Negative|Progesterone Receptor Positive|Recurrent Breast Carcinoma|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast CancerDrug: Lapatinib Ditosylate|Drug: Fulvestrant|Other: Placebo|Other: Laboratory Biomarker Analysishttps://ClinicalTrials.gov/show/NCT00390455
165624165624Out-of-Hospital CPAP for Severe Cardiogenic Pulmonary EdemaCompletedNo Results AvailableCardiogenic Pulmonary EdemaDevice: continuous positive airway pressurehttps://ClinicalTrials.gov/show/NCT00390442
165625165625Docetaxel and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsCompletedNo Results AvailableLung Cancer|Unspecified Adult Solid Tumor, Protocol SpecificDrug: docetaxel|Drug: erlotinib hydrochloridehttps://ClinicalTrials.gov/show/NCT00390429
165626165626Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal AdenocarcinomaCompletedNo Results AvailableStomach Neoplasms|Esophageal NeoplasmsDrug: Docetaxel, Cisplatin, Fluorouracil, Bevacizumab, Leucovorinhttps://ClinicalTrials.gov/show/NCT00390416
165627165627Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: R-(-)-gossypol acetic acid|Drug: temozolomide|Genetic: gene expression analysis|Genetic: mutation analysis|Genetic: protein expression analysis|Other: laboratory biomarker analysis|Other: pharmacological study|Procedure: adjuvant therapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00390403
165628165628Efficacy/Safety of Lansoprazole in Patients With Frequent HeartburnCompletedNo Results AvailableHeartburnDrug: Lansoprazolehttps://ClinicalTrials.gov/show/NCT00390390
165629165629Use of Hair to Diagnose Breast CancerRecruitingNo Results AvailableBreast CancerProcedure: Cutting scalp hairhttps://ClinicalTrials.gov/show/NCT00390377
165630165630Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous TherapyTerminatedHas ResultsColorectal CancerDrug: everolimus|Procedure: antiangiogenesis therapy|Procedure: biopsy|Procedure: diagnostic procedure|Procedure: gene expression analysis|Procedure: immunohistochemistry staining method|Procedure: laboratory biomarker analysis|Procedure: mutation analysis|Procedure: protein tyrosine kinase inhibitor therapy|Procedure: reverse transcriptase-polymerase chain reactionhttps://ClinicalTrials.gov/show/NCT00390364

* Görseller ve İçerik tekif hakkına sahip olabilir